{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Irvine",
      "address_1": "11 Morgan",
      "reason_for_recall": "Stason Pharmaceuticals is recalling Selegiline HCl tablets, USP 5mg 60 count bottle due to an out of specification result for dissolution of stability samples.",
      "address_2": "",
      "product_quantity": "17,013 units",
      "code_info": "Lot #: 14F030, 14F031, 14F032, Exp. June 2017; 15G022, Exp. July 2018",
      "center_classification_date": "20160902",
      "distribution_pattern": "North Carolina",
      "state": "CA",
      "product_description": "Selegiline HCL Tablets USP 5mg, 60- count bottles, Rx only, Manufactured by: Stason Pharmaceuticals, Inc. Irvine, CA 92618 Distributed by: Libertas Pharma, Inc. Montgomery, AL 36117. NDC 51862-146-06",
      "report_date": "20160914",
      "classification": "Class III",
      "openfda": {},
      "recalling_firm": "Stason Pharmaceuticals, Inc.",
      "recall_number": "D-1479-2016",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "75025",
      "termination_date": "20171023",
      "more_code_info": "",
      "recall_initiation_date": "20160823",
      "postal_code": "92618-2005",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}